teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - kõhu neoplasmid - antineoplastilised ained - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - hemorraagiline palavik, ebola - vaktsiinid - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
veregen salv
nordic pharma s.r.o. - sinekatehhiinid - salv - 100mg 1g 30g 1tk; 100mg 1g 15g 1tk
nordimet
nordic group b.v. - metotreksaadi - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastilised ained - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
octanate 500 süstelahuse pulber ja lahusti
octapharma ab - viii hüübimisfaktor - süstelahuse pulber ja lahusti - 500rÜ 1tk
octanate 1000 süstelahuse pulber ja lahusti
octapharma ab - viii hüübimisfaktor - süstelahuse pulber ja lahusti - 1000rÜ 1tk
imvanex
bavarian nordic a/s - modifitseeritud vaktsiin ankara - baieri põhja (mva-bn) viirus - smallpox vaccine; monkeypox virus - muud viirusevaktsiinide - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 ja 5. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
encepur children süstesuspensioon süstlis
bavarian nordic a/s - puukentsefaliidi koguviirus, inaktiveeritud - süstesuspensioon süstlis - 0,75mcg 0.25ml 0.25ml 1tk; 0,75mcg 0.25ml 0.25ml 10tk
encepur adults süstesuspensioon süstlis
bavarian nordic a/s - puukentsefaliidi koguviirus, inaktiveeritud - süstesuspensioon süstlis - 1,5mcg 0.5ml 0.5ml 10tk; 1,5mcg 0.5ml 0.5ml 1tk; 1,5mcg 0.5ml 0.5ml 20tk
ampisulcillin süste-/infusioonilahuse pulber
actavis nordic a/s - ampitsilliin+sulbaktaam - süste-/infusioonilahuse pulber - 1000mg+500mg 10tk